Rankings
▼
Calendar
CAMP Q3 2017 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena
CAMP
CAMP4 Therapeutics Corporation
$126M
Q3 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$90M
-0.8% YoY
Gross Profit
$37M
41.0% margin
Operating Income
$3M
3.5% margin
Net Income
$12M
13.6% margin
EPS (Diluted)
$0.34
QoQ Revenue Growth
+1.9%
Cash Flow
Operating Cash Flow
$25M
Free Cash Flow
$23M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$446M
Total Liabilities
$260M
Stockholders' Equity
$186M
Cash & Equivalents
$127M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$90M
$90M
-0.8%
Gross Profit
$37M
$38M
-2.1%
Operating Income
$3M
$4M
-19.8%
Net Income
$12M
$521,000
+2247.8%
Revenue Segments
Telematics Systems
$74M
83%
SoftwareAndSubscriptionServicesMember
$16M
17%
Geographic Segments
United States
$66M
73%
Europe, Middle East and Africa
$11M
13%
Canada
$4M
5%
Asia and Pacific Rim
$3M
4%
All other
$3M
3%
South America
$2M
2%
← FY 2017
All Quarters
Q4 2017 →